The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma

Immunomodulatory drugs (IMiDs) have potent anti-tumor activities in multiple myeloma (MM) and are able to enhance the cytotoxic function of natural killer (NK) cells, important effectors of the immune response against MM. Here, we show that these drugs can enhance the expression of the NKG2D and DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Fionda, Cinzia, Abruzzese, Maria Pia, Zingoni, Alessandra, Cecere, Francesca, Vulpis, Elisabetta, Peruzzi, Giovanna, Soriani, Alessandra, Molfetta, Rosa, Paolini, Rossella, Ricciardi, Maria Rosaria, Petrucci, Maria Teresa, Santoni, Angela, Cippitelli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695140/
https://www.ncbi.nlm.nih.gov/pubmed/26269456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695140/
https://www.ncbi.nlm.nih.gov/pubmed/26269456

Ejemplares similares